We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $751B
1-Year Est. Return 38.74%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+9.28%
1 Year Est. Return
+38.74%
3 Year Est. Return
+107.64%
5 Year Est. Return
+136.97%
10 Year Est. Return
+527.18%
AUM
$186B
AUM Growth
+$16.6B
Cap. Flow
+$3.17B
Cap. Flow %
1.7%
Top 10 Hldgs %
15.55%
Holding
3,227
New
50
Increased
2,329
Reduced
489
Closed
48

Sector Composition

Rank Sector Weight
1 Technology 18.3%
2 Financials 14.49%
3 Healthcare 13.31%
4 Industrials 10.23%
5 Consumer Discretionary 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTE
3101
DELISTED
PolarityTE, Inc. Common Stock
PTE
$89K ﹤0.01%
1,358
CHGA
3102
Change Agents Corp
CHGA
$2.27M
$87K ﹤0.01%
15
STXS icon
3103
Stereotaxis
STXS
$133M
$86K ﹤0.01%
+16,205
New +$64.4K
LUNA
3104
DELISTED
Luna Innovations Incorporated
LUNA
$86K ﹤0.01%
11,699
KRMD icon
3105
KORU Medical Systems
KRMD
$145M
$85K ﹤0.01%
+12,953
New +$63.2K
CKPT
3106
DELISTED
Checkpoint Therapeutics
CKPT
$83K ﹤0.01%
4,797
PHUN icon
3107
Phunware
PHUN
$41.1M
$81K ﹤0.01%
1,346
ICAD
3108
DELISTED
iCAD Inc
ICAD
$80K ﹤0.01%
+10,242
New +$73.1K
MTNB icon
3109
Matinas BioPharma
MTNB
$2.82M
$80K ﹤0.01%
702
OVID icon
3110
Ovid Therapeutics
OVID
$535M
$78K ﹤0.01%
+18,578
New +$58.7K
SONM icon
3111
DNA X Inc
SONM
$4.57M
$78K ﹤0.01%
+12
New +$59.2K
CTRC
3112
DELISTED
Centric Brands Inc. Common Stock
CTRC
$75K ﹤0.01%
34,283
VNRX icon
3113
VolitionRx Ltd
VNRX
$5.9M
$73K ﹤0.01%
769
GNLN icon
3114
Greenlane Holdings
GNLN
$1.93M
0
AXLA
3115
DELISTED
Axcella Health Inc. Common Stock
AXLA
$69K ﹤0.01%
+680
New +$74.7K
RTW
3116
DELISTED
RTW Retailwinds, Inc.
RTW
$67K ﹤0.01%
82,711
KODK icon
3117
Kodak
KODK
$895M
$62K ﹤0.01%
13,330
NIHD
3118
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$62K ﹤0.01%
28,127
NCSM
3119
DELISTED
NCS Multistage Holdings
NCSM
$60K ﹤0.01%
1,424
YGYI
3120
DELISTED
Youngevity International, Inc Common Stock
YGYI
$57K ﹤0.01%
17,188
GNSS icon
3121
Genasys
GNSS
$68.8M
$55K ﹤0.01%
16,638
BCLI
3122
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$49K ﹤0.01%
752
XCUR icon
3123
Exicure
XCUR
$8.97M
$49K ﹤0.01%
112
-146
-57% -$59.7K
ACER
3124
DELISTED
Acer Therapeutics Inc
ACER
$48K ﹤0.01%
11,934
JILL icon
3125
J. Jill
JILL
$353M
$47K ﹤0.01%
8,296

Similar funds

Charles Schwab's Q4 2019 Portfolio in Review

As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
  • Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
  • Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
  • Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
  • Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
  • Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.

Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.